John Daly, Director of CareCloud, Inc. (NASDAQ:CCLD), recently sold 5,000 shares of the company's common stock, according to a filing with the Securities and Exchange Commission. The healthcare technology company, currently valued at around $59 million, has shown impressive performance with a return of 141% over the past year. according to InvestingPro From the analysis, the stock is trading close to its fair value. The transaction was executed, on December 31, 2024, at a price of $3.87 per share, for a total value of $19,350. Following this sale, Daly retains ownership of 61,750 shares in the company. InvestingPro Subscribers can access 12 additional key insights into CCLD, including detailed analysis of its financial health, which is currently rated as Outstanding with an overall score of 3.16.
In other recent news, healthcare technology company CareCloud saw its Roth/MKM rating downgraded, moving from a Buy rating to a Neutral rating due to weak growth expectations in 2025. Despite recent cost-cutting measures, the company's growth outlook remains unimpressive , leading to a decrease in revenue expectations. This comes despite third-quarter revenue of $28.5 million, which met analyst expectations, and the company's adjusted EBITDA increased to $6.8 million.
CareCloud's third-quarter earnings report also revealed a slight decline in revenue, falling to $28.5 million from $29.3 million a year earlier. However, the company's adjusted EBITDA rose significantly year over year to $6.8 million, and its free cash flow improved significantly, reaching $10.3 million.
The company repaid its credit line in full and announced plans to resume dividend payments in March 2025. CareCloud also reported positive GAAP net income of $3.1 million, up from a loss of $2.7 million in Q3 2023. These are the latest developments that shape the company's trajectory.
This article was created with the power of artificial intelligence and reviewed by an editor. For more information, see our terms and conditions.
